TKO — TKO Group Holdings, Inc.

The sell-side is unambiguously bullish: 17 Buy / 2 Hold / 0 Sell, consensus rating 'Buy', and targets of $227 average ($210 low, $235 high) after Guggenheim ($230 to $235) and Morgan Stanley ($225 to $230) raised numbers in August 2026 following the Q2 beat and the raised FY26 guide ($5.775–5.825B revenue, $2.275–2.305B adjusted EBITDA). The tape disagrees. As of 2026-09-13, TKO was -6.42% over three months and -2.19% over six months, below its 200-day SMA, with RSI(14) at 50.58 — dead neutral — and the price 8% off the 52-week low yet still 16% below the high. Money is not confirming the narrative: analysts are paying for cash flow, while the market is discounting the GAAP earnings optics (63x TTM) and the acquisition-complicated growth history. Net: bullish research, neutral tape.

The three-year quarterly series is contaminated by two discontinuities that the deterministic score's own notes flag: revenue fell -58% from Q3 2024 ($1,540.7M) to Q4 2024 ($642.2M) and jumped +54% from Q4 2025 ($1,038.0M) to Q1 2026 ($1,596.9M), consistent with the consolidation of the acquired Endeavor agency assets (IMG, On Location) and event-timing shifts rather than organic momentum. On the cleanest available like-for-like reads, growth is inflecting up, not decelerating: Q1 2026 revenue of $1,596.9M grew +25.9% YoY vs. Q1 2025's +3.8% comp, and Q2 2026's $1,547.1M grew +18.2% YoY vs. Q2 2025's +9.7% comp. Margins are also structurally improving: gross margin rose to 64.0% in Q2 2026 ($991.0M) from 56.0% ($732.7M) a year earlier, and to 54.0% in Q1 2026 from 47.3% in Q1 2025. The problem is that gross-margin expansion is not reaching the operating line: operating margin actually slipped to 27.8% in Q2 2026 from 29.5% in Q2 2025, and to 21.2% in Q1 2026 from 22.5% — the acquired agency businesses are lower-margin and drag the blended mix, and SG&A/event costs are absorbing the gross-margin gain. Earnings remain thin: TTM net income of $229.6M on TTM revenue of $5,301.9M is a 4.3% net margin, versus $1,057.9M of TTM operating income — the $828M gap is interest on $4.58B of long-term debt plus intangible amortization, which is a capital-structure and purchase-accounting issue, not an operating collapse. Cash generation is the standout: TTM free cash flow of $1,672M (capex only $123M, ~2% of revenue), with the accruals ratio at -1.67% — cash earnings running ahead of reported earnings, a genuinely healthy quality signal. Caveat: Q1 2026 operating cash flow of $694.5M was roughly double every other quarter in the window, so I would normalize annual FCF to ~$1.45–1.55B rather than $1.67B. Verdict: revenue and gross margin are in a real uptrend, operating leverage is not yet showing, and reported GAAP earnings materially understate cash economics.

Genuinely split depending on the yardstick, and that split is the whole story. As of 2026-09-13, at $190.31: TTM P/E is 63.0x on $3.069 of TTM EPS, and forward P/E is 41.0x on the $4.64 next-FY consensus EPS — expensive in absolute terms. But EV is ~$17.30B (market cap $14.27B + $4.58B long-term debt − $1.55B cash), which is only ~7.6x the FY26 adjusted EBITDA guidance midpoint of $2.29B, and TTM FCF of $1,672M is an 11.7% FCF yield (10.9% on my normalized ~$1.55B). P/S of 2.69x sits well under the 5-year average of 4.09x, which is what drives the 'Cheap vs. its own history' tag — but I'd discount that signal, because the 5-year average P/S was set when TKO was UFC + WWE only, a structurally higher-margin, higher-multiple mix than today's business with two low-margin agencies bolted on. The 5-year average P/E of 326.65x is not usable (only 4 years of data, early periods with minimal or negative EPS). Net call: fair on cash flow with a modest tilt toward cheap, clearly expensive on GAAP earnings, and the gap is purchase-accounting amortization that will not go away quickly given ~$13B of non-current assets on a $16.26B balance sheet. This is 'fair-to-slightly-cheap,' not a bargain.

The stock is being priced off cash flow, not earnings, and investors need to be explicit about that. At $190.31 you are paying 41.0x next-FY EPS of $4.64 — a multiple that only makes sense if you believe the $1.0B+ of annual amortization and the ~$300M of interest expense are temporary drags rather than real economic costs, and if the FY27 EPS number is materially higher than FY26's. Meanwhile you are paying only ~7.6x FY26 guided adjusted EBITDA and ~11% of market cap in free cash flow. Read: the market has already paid for about two more years of the current growth trajectory, so a beat-and-raise cadence (like the Aug 3, 2026 Q2 print) is table stakes, not upside. The asymmetry is ugly in the near term — every 1x of forward P/E is worth about $4.64/share, so a de-rate from 41x to 35x is a ~15% drawdown with no change in estimates. The bull case hinges on EPS inflecting as debt is paid down (net leverage is only ~1.3x FY26E adjusted EBITDA, and net debt fell from $2.99B at Q4 2025 to $3.03B at Q2 2026 while cash sits at $1.55B) — if amortization rolls off and interest falls, GAAP EPS could grow far faster than EBITDA, and today's 41x forward P/E would look cheap in hindsight. That is the bet. The bear case is that analysts are capitalizing a FCF number ($1.67B TTM) that included an anomalous $694.5M Q1 2026 operating cash flow quarter; on a normalized ~$1.5B, the FCF yield is ~10.9% and the margin for error shrinks.

As of 2026-09-13, the technical read is range-bound and directionless, with a mild bearish tilt in the medium term. RSI(14) of 50.58 is the definition of neutral — no oversold bounce setup, no overbought exhaustion. Price of $190.31 sat -0.33% versus the 20-day SMA (implied ~$190.9), +1.03% versus the 50-day (implied ~$188.4), and -3.64% versus the 200-day (implied ~$197.5) — meaning short-term averages are clustered and flat around $188–191, while the longer trend still caps the stock from above. Returns: +2.31% over one week, but -2.48% over one month, -6.42% over three months, and -2.19% over six months, i.e., the one-week bounce is a counter-trend twitch inside a three-month slide. With a beta of only 0.643 and the price at $190.31 versus a $176–226.94 52-week range, this is a low-volatility name chopping in the lower-middle of its band. Entry implication: there is no technical edge here — not oversold enough to chase the dip, not above the 200-day to confirm a trend reversal. A close above ~$197–198 (the implied 200-day) would validate the recent bounce and open the mid-$200s; failure to hold the $188 area (the 20/50-day cluster) puts the $176 low back in play. Wait for one of those two levels to break rather than buying the middle.

• Live-events and premium-experience demand: gate, site-fee, and On Location hospitality revenue has stayed resilient through macro anxiety, but TKO is ultimately selling discretionary entertainment — a genuine consumer pullback would hit ticket pricing and sponsorship budgets with a lag.
• Media-rights and streaming cycle: the migration of live sports to streaming platforms gives appointment-viewing combat sports real pricing power at renewal, but renewals are lumpy and a single disappointing deal (or a partner's streaming retrenchment) can reset the long-term growth rate overnight — UFC programming on Paramount+ is the visible current datapoint.
• Rates and refinancing: $4.58B of long-term debt against $1.55B of cash and ~$2.29B of FY26E adjusted EBITDA. Net leverage of ~1.3x is comfortable, but interest expense is the single largest reason $1.06B of TTM operating income becomes $230M of TTM net income; higher-for-longer rates delay the EPS inflection the bull case depends on.
• Regulatory, antitrust, and governance: TKO's scale in combat sports, its control over fighter pay and event distribution, plus dual-class share structure and Endeavor/Silver Lake influence and a non-controlling interest, draw ongoing scrutiny and can sustain a structural valuation discount.
• Event-calendar and cost-mix lumpiness: quarterly revenue and cost swings tied to numbered UFC events, marquee WWE properties, and preparation spend for long-dated spectacles (e.g., LA 2028 Olympics via On Location) make any single quarter a poor trend proxy.

• Q3 2026 earnings, expected early-to-mid November 2026 — the first real checkpoint on the raised FY26 guidance of $5.775–5.825B revenue and $2.275–2.305B adjusted EBITDA, and the market's chance to confirm the Q2 momentum was not a timing artifact.
• A dense H2 2026 event slate — a heavier cadence of UFC numbered events and Fight Nights alongside marquee WWE properties such as SummerSlam — driving gate, site fees, streaming/PPV, and sponsorship revenue in the second half.
• Media-rights renewals and distribution expansion, including UFC's Paramount+ integration and any new international rights agreements; this is the biggest single swing factor in the long-term growth rate.
• Continued capital return — the ~1.55% dividend plus the $800M accelerated share repurchase and subsequent 10b5-1 plan; a new authorization or accelerated debt paydown would directly lift EPS by shrinking interest and share count.
• Deleveraging math: net debt of ~$3.03B against ~$1.5B+ of normalized annual free cash flow means roughly two years of cash generation could meaningfully cut interest expense and unlock the GAAP EPS inflection.
• Long-dated optionality from On Location's pipeline, including hospitality packages tied to major spectacles such as Super Bowl LXI and LA 2028.

• Valuation leaves no cushion on earnings: 63.0x TTM P/E and 41.0x forward P/E on $4.64 next-FY EPS means a modest miss or a one-turn de-rate costs roughly $4.64/share, and the current price already embeds FY27 growth that has not been delivered yet.
• Weak returns on the capital actually spent: ROIC of 6.2% and ROE of 5.2% on a $3.40B book equity and $16.26B asset base suggest the WWE/IMG/On Location acquisition prices were rich; if those assets do not compound, the 'cheap on cash flow' argument loses its foundation.
• Reported growth is acquisition-distorted: the -58% (Q3 2024 to Q4 2024) and +54% (Q4 2025 to Q1 2026) revenue swings the score flags mean headline growth partly reflects consolidation accounting and event timing, not verified organic momentum.
• Balance sheet and leverage: long-term debt of $4.58B, up from $2.72B in mid-2025, with D/E of 1.46x and a current ratio of 1.23x — manageable at ~1.3x net leverage but sensitive to both rates and any EBITDA disappointment.
• Free-cash-flow quality: Q1 2026 operating cash flow of $694.5M was roughly double every other quarter in the three-year window, so a chunk of the TTM $1,672M FCF may be working-capital timing; on a normalized ~$1.5B the FCF yield is ~10.9%, not 11.7%, and the cushion is thinner than it looks.
• Media-partner concentration and counterparty risk: a large share of revenue comes from a small number of media and distribution partners, and a weak renewal or a partner's own streaming pullback would hit estimates and the multiple simultaneously.

This is a good operating story at a fair-to-slightly-cheap price with an unproven return-on-capital record — not a screaming buy. The positives are real: Q2 2026 revenue +18.2% YoY and Q1 2026 +25.9% YoY on the current perimeter, gross margin up ~800bps YoY to 64.0%, TTM free cash flow of $1,672M (~11.7% of market cap), net leverage of only ~1.3x FY26E adjusted EBITDA, negative accruals (-1.67%), and management raising FY26 guidance on Aug 3, 2026. The negatives are equally real: 41x forward P/E with a 4.3% GAAP net margin, ROIC of just 6.2%, $4.58B of debt that eats most of operating income before it reaches EPS, acquisition-driven revenue discontinuities that make the growth trend hard to verify, and a stock trading below its 200-day with -6.4% three-month returns even as estimates rise. My independent fair value of ~$215 implies roughly 13% upside — less than the sell-side's $227 — which is adequate but not compelling enough to be aggressive given the low returns on invested capital and the absence of technical confirmation. I'd want either a decisive move above the implied ~$197.5 200-day or two more quarters of clean, ex-acquisition organic growth before treating this as more than a hold.

I used two cash-flow-anchored methods and averaged them, because GAAP EPS is distorted by purchase-accounting amortization and $4.58B of debt: (1) 9.0x EV/FY26E adjusted EBITDA of $2.29B (guidance midpoint) gives ~$20.6B EV, less $3.03B net debt = ~$17.6B equity, or ~$234/share on ~75M shares; (2) a 9.5% required FCF yield on ~$1.55B of normalized annual FCF (TTM $1,672M less the anomalous $694.5M Q1 2026 working-capital benefit) gives ~$218/share. Averaging those (~$226) and applying a ~5% discount for the add-back-heavy adjusted EBITDA definition, the 6.2% ROIC, and the dual-class/NCI governance complexity yields ~$215 — modestly below the $227 analyst consensus and ~13% above the $190.31 close as of 2026-09-13.